Oliver Nehls

879 total citations
29 papers, 700 citations indexed

About

Oliver Nehls is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Oliver Nehls has authored 29 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 17 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Oliver Nehls's work include Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Colorectal and Anal Carcinomas (7 papers) and Colorectal Cancer Treatments and Studies (5 papers). Oliver Nehls is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Colorectal and Anal Carcinomas (7 papers) and Colorectal Cancer Treatments and Studies (5 papers). Oliver Nehls collaborates with scholars based in Germany, United States and Austria. Oliver Nehls's co-authors include Bodo Klump, Michael Gregor, Holger G. Hass, Rainer Porschen, F Borchard, Mario Sarbia, A Greschniok, Stephan Kaiser, Hendrik‐Tobias Arkenau and J. T. Hartmann and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer.

In The Last Decade

Oliver Nehls

28 papers receiving 682 citations

Peers

Oliver Nehls
Daitaro Yoshikawa Japan
Moon Soo Lee South Korea
Kouichiro Tsugawa Japan
Ji Min Park United States
Jean‐Marc Ferraz France
Teruyuki SAKAGUCHI Japan
Richard M. Goldberg United States
Guanghai Dai China
Fabiola Lorena Rojas Llimpe Italy
Daitaro Yoshikawa Japan
Oliver Nehls
Citations per year, relative to Oliver Nehls Oliver Nehls (= 1×) peers Daitaro Yoshikawa

Countries citing papers authored by Oliver Nehls

Since Specialization
Citations

This map shows the geographic impact of Oliver Nehls's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Nehls with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Nehls more than expected).

Fields of papers citing papers by Oliver Nehls

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Nehls. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Nehls. The network helps show where Oliver Nehls may publish in the future.

Co-authorship network of co-authors of Oliver Nehls

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Nehls. A scholar is included among the top collaborators of Oliver Nehls based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Nehls. Oliver Nehls is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hass, Holger G., Jürgen Jobst, Ulrich Vogel, Michael Scheurlen, & Oliver Nehls. (2014). Overexpression of Tumor-Associated Trypsin Inhibitor (SPINK1/TATI) in Hepatitis C-Associated Hepatocellular Carcinoma: Potential Implications for Viral Hepatocarcinogenesis. Oncology Research and Treatment. 37(12). 732–738. 11 indexed citations
2.
Sinn, Marianne, Sven Bischoff, Oliver Nehls, et al.. (2012). Biliary Tract Cancer: A Survey Regarding the Current Oncological Daily Care Practice in Germany. Onkologie. 35(12). 755–760. 1 indexed citations
3.
4.
Dollinger, Matthias, Christine Lautenschlaeger, J. Leßke, et al.. (2010). Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trial. BMC Cancer. 10(1). 457–457. 10 indexed citations
5.
Nehls, Oliver, Holger G. Hass, Chih‐Jen Hsieh, et al.. (2009). Prognostic implications of BAX protein expression and microsatellite instability in all non-metastatic stages of primary colon cancer treated by surgery alone. International Journal of Colorectal Disease. 24(6). 655–663. 14 indexed citations
6.
7.
Hass, Holger G., C.–Thomas Bock, Oliver Nehls, & Stephan Kaiser. (2009). Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B. Journal of Gastroenterology. 44(8). 871–877. 9 indexed citations
8.
Nehls, Oliver, Helmut Oettle, J. T. Hartmann, et al.. (2008). Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial. British Journal of Cancer. 98(2). 309–315. 95 indexed citations
9.
Hartmann, Jörg T., Salah‐Eddin Al‐Batran, D. Quietzsch, et al.. (2007). Mitomycin C plus Infusional 5-Fluorouracil in Platinum-Refractory Gastric Adenocarcinoma: An Extended Multicenter Phase II Study. Oncology Research and Treatment. 30(5). 235–240. 10 indexed citations
10.
Nehls, Oliver, Mario Sarbia, F Borchard, et al.. (2007). Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX. British Journal of Cancer. 96(9). 1409–1418. 60 indexed citations
11.
Nehls, Oliver, Holger G. Hass, Martin Weber, et al.. (2006). Sarcoidosis mimicking cholangiocarcinoma. Endoscopy. 38(S 2). E65–E66. 1 indexed citations
12.
Nehls, Oliver, Chih‐Jen Hsieh, Mario Sarbia, et al.. (2004). Low bax protein expression correlates with disease recurrence in preoperatively irradiated rectal carcinoma. International Journal of Radiation Oncology*Biology*Physics. 61(1). 85–91. 22 indexed citations
13.
Nehls, Oliver, Rainer Porschen, Michael Gregor, et al.. (2004). Malassimilationsyndrom. Der Internist. 45(2). 211–216. 1 indexed citations
14.
Nehls, Oliver, Michael Gregor, & Bodo Klump. (2004). Serum and Bile Markers for Cholangiocarcinoma. Seminars in Liver Disease. 24(2). 139–154. 133 indexed citations
15.
Nehls, Oliver, Helmut Oettle, J.T. Hartmann, et al.. (2004). A multicenter phase II study of capecitabine plus oxaliplatin (CapOx) in advanced biliary system adenocarcinomas. Journal of Clinical Oncology. 22(14_suppl). 4091–4091. 4 indexed citations
16.
Klump, Bodo, Oliver Nehls, C.‐J. Hsieh, et al.. (2003). Molecular lesions in colorectal cancer: impact on prognosis?. International Journal of Colorectal Disease. 19(1). 23–42. 61 indexed citations
17.
Hartmann, Jakob, Karin Oechsle, D. Quietzsch, et al.. (2003). Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study. British Journal of Cancer. 89(11). 2051–2056. 12 indexed citations
18.
Klump, Bodo, C.‐J. Hsieh, Oliver Nehls, et al.. (2003). Methylation status of p14ARF and p16INK4a as detected in pancreatic secretions. British Journal of Cancer. 88(2). 217–222. 38 indexed citations
19.
Nehls, Oliver, R Porschen, Michael Gregor, & Bodo Klump. (2001). Stellenwert von Oxaliplatin in der Therapie des fortgeschrittenen kolorektalen Karzinoms. Zeitschrift für Gastroenterologie. 39(12). 1033–1047. 2 indexed citations
20.
Nehls, Oliver, Bodo Klump, Karlheinz Holzmann, et al.. (1999). Influence of p53 status on prognosis in preoperatively irradiated rectal carcinoma. Cancer. 85(12). 2541–2548. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daitaro Yoshikawa Breakdown of academic impact, for papers by Moon Soo Lee Breakdown of academic impact, for papers by Kouichiro Tsugawa Breakdown of academic impact, for papers by Ji Min Park Breakdown of academic impact, for papers by Jean‐Marc Ferraz Breakdown of academic impact, for papers by Teruyuki SAKAGUCHI Breakdown of academic impact, for papers by Richard M. Goldberg Breakdown of academic impact, for papers by Guanghai Dai Breakdown of academic impact, for papers by Fabiola Lorena Rojas Llimpe
Rankless by CCL
2026